Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Single Arm Clinical Trial Assessing the Efficacy and Safety of BIntrafusp Alfa (M7824) in Previously Treated Advanced Malignant Pleural MESothelioma (BIMES)

NCT05005429 is registered in ClinicalTrials.gov with Fundación GECP as lead sponsor.

NCT NCT05005429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05005429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Single Arm Clinical Trial Assessing the Efficacy and Safety of BIntrafusp Alfa (M7824) in Previously Treated Advanced Malignant Pleural MESothelioma (BIMES)
Lead sponsor
Fundación GECP
Phase
Phase 2
Overall status
Completed
Start date
September 20, 2021
Completion date
February 1, 2024
Enrollment
47 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

mesothelioma; lung